KRKA: 2021 Unaudited Semi-Annual Report of the Krka group and Krka, d. d., Novo mesto

2021-07-29 08:15

publikacja
2021-07-29 08:15

Spis treści:

3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
2021_Unaudited_Semi_Annual_Report_of_the_Krka_group_and_Krka_Novo_mesto_.pdf (REPORT)
Press_Release.pdf (REPORT)

POLISH FINANCIAL SUPERVISION AUTHORITY
		UNI - EN REPORT No		21	/	2021
Date of issue:	2021-07-29
Short name of the issuer
KRKA
Subject
2021 Unaudited Semi-Annual Report of the Krka group and Krka, d. d., Novo mesto
Official market - legal basis
art. 56. 1. 2 of Act on Public Offering.
Unofficial market - legal basis
Contents of the report:
Based on the provisions of the Rules of the Ljubljana Stock Exchange, d. d., Ljubljana and Article 136 of the Market in Financial Instruments Act, Krka, d. d., Novo mesto publishes the 2021 Unaudited Semi-Annual Report of the Krka group and Krka, d. d., Novo mesto. The report will be published on the Company's website (www.krka.biz) from 29 July 2021 onwards, for a period of at least 10 years.
Annexes
File			Description
2021 Unaudited Semi Annual Report of the Krka group and Krka Novo mesto .pdf2021 Unaudited Semi Annual Report of the Krka group and Krka Novo mesto .pdf			2021 Unaudited Semi-Annual Report of the Krka group and Krka Novo mesto
Press Release.pdfPress Release.pdf			Press Release

KRKA, TOVARNA ZDRAVIL D.D.

(fullname of the issuer)

KRKA

Farmaceutyczny (far)

(short name of the issuer)

(sector according to clasification
of the WSE in Warsow)

8501

Nove Mesto

(post code)

(city)

Smarjeska

(street)

(number)

+386 7 331 21 11

+386 7 332 15 37

(phone number)

(fax)

(e-mail)

(web site)

nie dotyczy

(NIP)

(REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date	Name	Position / Function	Signature
2021-07-29	Jože Colarič	President of the Management Board and CEO

Ważne linki